{"_id": "20190901-3", "pgId": 2797422, "numDataRows": 5, "numCols": 5, "pgTitle": "Takeda Oncology", "numNumericCols": 0, "tableCaption": "Product Portfolio", "headers": [{"text": "Brand Name", "isNumeric": false, "links": []}, {"text": "Drug Name(s)", "isNumeric": false, "links": []}, {"text": "Indication", "isNumeric": false, "links": []}, {"text": "Date Approved in USA", "isNumeric": false, "links": []}, {"text": "Partner", "isNumeric": false, "links": []}], "rows": [[{"text": "VELCADE", "isNumeric": false, "links": []}, {"text": "bortezomib", "isNumeric": false, "links": []}, {"text": "Velcade is indicated for the front-line treatment of multiple myeloma and for patients with mantle cell lymphoma who have received at least 1 prior therapy.", "isNumeric": false, "links": []}, {"text": "05-13-2003", "isNumeric": false, "links": []}, {"text": "Ortho Biotech and Janssen-Cilag, members of the Johnson & Johnson Family of Companies, are responsible for commercialization of VELCADE in Europe and the rest of the world.", "isNumeric": false, "links": []}], [{"text": "MEPACT", "isNumeric": false, "links": []}, {"text": "mifamurtide", "isNumeric": false, "links": []}, {"text": "Mifamurtide is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of cases.", "isNumeric": false, "links": []}, {"text": "March 2009", "isNumeric": false, "links": []}, {"text": "N/A", "isNumeric": false, "links": []}], [{"text": "ADCETRIS", "isNumeric": false, "links": []}, {"text": "brentuximab vedotin", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/brentuximab_vedotin"]}, {"text": "Adcetris is an antibody-drug conjugate approved to treat anaplastic large cell lymphoma (ALCL) and Hodgkin lymphoma.", "isNumeric": false, "links": []}, {"text": "10-31-2012", "isNumeric": false, "links": []}, {"text": "Seattle Genetics is responsible for commercialization of ADCETRIS in the United States, and Takeda Oncology is responsible in Europe and the rest of the world.", "isNumeric": false, "links": []}], [{"text": "NINLARO", "isNumeric": false, "links": []}, {"text": "Ixazomib", "isNumeric": false, "links": ["http://www.wikipedia.org/wiki/Ixazomib"]}, {"text": "The first oral proteasome inhibitor to treat multiple myeloma", "isNumeric": false, "links": []}, {"text": "November 2015", "isNumeric": false, "links": []}, {"text": "", "isNumeric": false, "links": []}]]}